MS700568_0199: Prospective Observational Study Aimed at Evaluating Treatment Satisfaction and Effectiveness in Patients with Relapsing Multiple Sclerosis Starting CLADRibinE TAbLets (CLADREAL) First published 17/10/2022 Last updated 31/03/2026 EU PAS number:EUPAS49334 Study Ongoing